drugset / Trial / NCT07022496
Assessment of Oral Caffeine Intake in Changing the Severity of Acute Migraine Attack Using VAS Score Among Patients Attending Headache and Neurology Outpatients Clinic of Ainshams University Hospitals
RandomizedParallel-groupOpen-labelTreatment
Summary
Caffeine extracted from green tea to abort acute attack of Migraine
Timeline
- Start
- 2023-04-26
- Primary completion
- 2025-07
- Completion
- 2025-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Caffeine | Small molecule | 200 mg | — |
| Background | Acetaminophen | Small molecule | 250 mg | — |
| Background | Aspirin | Small molecule | 75 mg | — |
| Background | Aspirin | Small molecule | 81 mg | — |
| Background | Aspirin | Small molecule | 250 mg | — |
| Background | Sumatriptan | Unknown | — | — |